Aspirin trial to examine if it can stop cancer returning
21 October 2015
The world’s largest clinical trial to examine whether aspirin can prevent cancers returning has begun in the UK.
The trial will run across 100 UK centres and involve around 11,000 people who have had treatment or are having treatment for early cancer.
The study which is funded by Cancer Research UK and the NIHR (the research arm of the NHS) will involve patients taking a tablet everyday for five years. Researchers will compare groups of patients taking different doses of aspirin with people taking placebo pills.
If it is proven to work, scientists say it would be “game-changing” by proving a cheap and effective way to help more patients survive.